Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PIEX 4
- Development stage
- Unknown
- Lead developer
- Becanex
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Inhalation, Oral
01
Overview
PIEX 4 is a high-potency, plant-identical full-spectrum cannabis extract developed by Becanex. It is standardized to contain approximately 75% tetrahydrocannabinol (THC) and less than 1% cannabidiol (CBD). Extracted from the Pink Kush cultivar (an Indica-dominant hybrid strain) using a proprietary gentle one-step extraction process, PIEX 4 preserves the natural cannabinoid and terpene profile of the original flower, including key terpenes such as beta-caryophyllene, nerolidol, alpha-bisabolol, alpha-humulene, linalool, and limonene. The extract is fully decarboxylated and free of additives or excipients. It is designed for medical cannabis compounding and administration, including inhalation via vape cartridges or oral formulations like oils and capsules, primarily for the management of conditions like chronic pain and migraine.
- Brand names
- Becanex PIEX 4PIEX 4PIEX4PIEX-4
- Other names
- 75% THC Rohextrakt75% THC concentrateBecanex PIEX 4 75% THC RohextraktPIEX 4 75% THC Rohextrakt
02
Targets
CNR1 (Cannabinoid receptor 1)
Beyond the preview
Go deeper on PIEX 4.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PIEX 4.